Singapore questions cervical cancer vaccine for teens

	Tweet

A Singapore government minister questioned on Friday the effectiveness of cervical cancer vaccination for teenagers and said such prevention sends out a message that teenage sex is condoned by the community.

Medical experts say vaccination on girls is the best measure to prevent cervical cancer, which kills up to 280,000 women worldwide a year, mostly in the developing world.

In a speech to open the Asian Oncology Summit in Singapore, Balaji Sadasivan, junior minister at the Ministry of Foreign Affairs, questioned the long-term effectiveness of the vaccine, saying the government needs more information.

"From an ethical standpoint, the issue of consent must be viewed in the local context where the community’s moral viewpoint is that offering such a vaccination programme sends out a message that teenage sex is condoned by the community,” Harvard-trained neurosurgeon Sadasivan said.

“As a country with a lower incidence of cervical cancer, the risk benefit ratio of vaccination will be lower in Singapore. We should therefore be cautious in making any national recommendation with regard to vaccination.”

Summit participant and 2008 Noble Laureate Harald zur Hausen, who discovered that human papilloma virus caused cervical cancer, disagreed.

“Data shows that the vaccine can be effective at least seven years and after 10 years you may get a boost again. That should do it,” zur Hausen told Reuters in an interview.

Zur Hausen, whose discoveries made it possible to diagnose cervical cancer and led to the development of two vaccines that prevent it, said vaccination in young girls, as early as 7 years old, did not cause early sex among teens in Europe.

“It might be a point which you have seen in Singapore, but at least in Europe, this point doesn’t play any real significant role,” he said.

SINGAPORE (Reuters)

RELATED STORIES:
15 Common Myths About Cervical Cancer   Higher rates of cervical cancer amongst immigrants   Cervical cancer drops, but disparities persist   Gates backs cervical cancer vaccines for poor   Common virus kills cancer   Merck’s cervical cancer vaccine on sale in Europe   Urinary tract cancer associated with Chinese herbal products containing aristolochic acid   Adding test for cervical cancer raises costs: study   Study determines costs of breast and cervical cancer detection among low-income women   How Medical Center Research Led to New Cervical Cancer Vaccine   Merck says US CDC endorses cervical cancer vaccine   Aspirin Merits Testing for Prevention of Cervical Cancer in HIV-Infected Women   Hysterectomy for cervical cancer feasible in obese women   Cervical cancer screening rates low in poor areas   HPV Vaccine Reduces Abnormal Pap Test Results   Study indicates vaccine prevents cervical cancer   Cervical cancer survivors prone to other cancers   Newer cervical cancer test no better than the old?   Smoking raises virus-related cervical cancer risk   HPV screen-and treat-intervention effective in cervical cancer prevention   Merck cervical cancer shot gives 5-year protection   Scientists identify how virus triggers cervical and mouth cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]